Key points from article :
Vaccitech has raised £20m from investors including Google parent Alphabet.
Running clinical studies on an experimental shot to prevent Middle East Respiratory Syndrome (Mers).
Vaccine works by using proteins found in the core of the virus rather than those on its surface.
Also stimulates T-cells rather than antibodies.
First time a universal flu vaccine has progressed beyond phase one clinical testing.
Also studying therapeutic prostate cancer vaccine for use with an immunotherapy drug.
Vaccitech is a spin-out founded by scientists at Oxford University’s Jenner Institute.
